Discovery of γ-secretase inhibitors efficacious in a transgenic animal model of Alzheimer's disease

被引：24
|
作者：
Asberom, Theodros
Zhao, Zhiqiang
Bara, Thomas A.
Clader, John W.
Greenlee, William J.
Hyde, Lynn A.
Josien, Hubert B.
Li, Wei
McPhail, Andrew T.
Nomeir, Amin A.
Parker, Eric M.
Rajagopalan, Murali
Song, Lixin
Wong, Gwendolyn T.
Zhang, Lili
Zhang, Qi
Pissarnitski, Dmitri A.
机构：
[1] Schering Plough Res Inst, Dept Chem Res, Kenilworth, NJ 07033 USA
[2] Schering Plough Res Inst, Dept Cent Nervous Syst, Kenilworth, NJ 07033 USA
[3] Duke Univ, Dept Chem, Durham, NC 27708 USA
[4] Schering Plough Res Inst, Dept Drug Metab & Pharmacokinet, Kenilworth, NJ 07033 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 02期
关键词：
Alzheimer's disease; gamma-secretase inhibitors; Kulinkovich reaction;
D O I：
10.1016/j.bmcl.2006.10.011
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Attachment of the cyclopropylcarbamate group to the piperidine core of gamma-secretase inhibitors leads to a dramatic increase of their in vitro potency. Strategies for subsequent improvement of the in vivo pharmacokinetic profile of the series are discussed. Resulting compounds significantly reduce A beta levels in TgCRND8 mice after a single PO dosing at 30 mpk. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：511 / 516
页数：6
相关论文
共 50 条
  • [21] γ-Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State
    Panza, Francesco
    Frisardi, Vincenza
    Imbimbo, Bruno P.
    Capurso, Cristiano
    Logroscino, Giancarlo
    Sancarlo, Daniele
    Seripa, Davide
    Vendemiale, Gianluigi
    Pilotto, Alberto
    Solfrizzi, Vincenzo
    CNS NEUROSCIENCE & THERAPEUTICS, 2010, 16 (05) : 272 - 284
  • [22] γ-secretase inhibitors for Alzheimer's disease: Balancing efficacy and toxicity
    Barten D.M.
    Meredith Jr. J.E.
    Zaczek R.
    Houston J.G.
    Albright C.F.
    Drugs in R&D, 2006, 7 (2) : 87 - 97
  • [23] β-secretase inhibitors for Alzheimer's disease: heading in the wrong direction?
    Selkoe, Dennis
    LANCET NEUROLOGY, 2019, 18 (07): : 624 - 626
  • [24] Beta-secretase inhibitors for treatment of Alzheimer's disease
    Brodney, Michael A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [25] Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease
    D'Onofrio, Grazia
    Panza, Francesco
    Frisardi, Vincenza
    Solfrizzi, Vincenzo
    Imbimbo, Bruno P.
    Paroni, Giulia
    Cascavilla, Leandro
    Seripa, Davide
    Pilotto, Alberto
    EXPERT OPINION ON DRUG DISCOVERY, 2012, 7 (01) : 19 - 37
  • [26] -secretase inhibitors for Alzheimer's disease: identification using pharmacoinformatics
    Islam, Md Ataul
    Pillay, Tahir S.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2019, 37 (02): : 503 - 522
  • [27] Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's disease
    Chen, Jian Jeffrey
    Liu, Qingyian
    Yuan, Chester
    Gore, Vijay
    Lopez, Patricia
    Ma, Vu
    Amegadzie, Albert
    Qian, Wenyuan
    Judd, Ted C.
    Minatti, Ana E.
    Brown, James
    Cheng, Yuan
    Xue, May
    Zhong, Wenge
    Dineen, Thomas A.
    Epstein, Oleg
    Human, Jason
    Kreiman, Charles
    Marx, Isaac
    Weiss, Matthew M.
    Hitchcock, Stephen A.
    Powers, Timothy S.
    Chen, Kui
    Wen, Paul H.
    Whittington, Douglas A.
    Cheng, Alan C.
    Bartberger, Michael D.
    Hickman, Dean
    Werner, Jonathan A.
    Vargas, Hugo M.
    Everds, Nancy E.
    Vonderfecht, Steven L.
    Dunn, Robert T., II
    Wood, Stephen
    Fremeau, Robert T., Jr.
    White, Ryan D.
    Patel, Vinod F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (04) : 767 - 774
  • [28] Beta-secretase as a target for Alzheimer’s disease drug discovery: an overview of in vitro methods for characterization of inhibitors
    Francesca Mancini
    Angela De Simone
    Vincenza Andrisano
    Analytical and Bioanalytical Chemistry, 2011, 400 : 1979 - 1996
  • [29] Transgenic animal models of Alzheimer's disease pathology
    Cordell, B
    NOVEL SYSTEMS FOR THE STUDY OF HUMAN DISEASE: FROM BASIC RESEARCH TO APPLICATIONS, 1998, : 273 - 281
  • [30] β-amyloid reductions in brain, plasma and CSF of a transgenic mouse model of Alzheimer's disease with a γ-secretase inhibitor
    Barten, DM
    Guss, VL
    Corsa, JA
    Loo, AT
    Hansel, SB
    Zheng, M
    Munoz, B
    Srinivasan, K
    Robertson, B
    Hendrick, JP
    Anderson, JJ
    Verdoorn, TA
    Roberts, SB
    Felsenstein, KM
    Smith, DW
    NEUROBIOLOGY OF AGING, 2004, 25 : S82 - S82
12345